March 2026 Evidentiary Hearings: March Report #2752

Jamie from the RIGGEDLabs Podcast delivers a deep dive into the ongoing evidentiary hearings surrounding the Massachusetts drug lab scandal, focusing on the Hinton Lab's systemic failures and the cover-up of widespread misconduct. He details how chemists like Annie Dukin, Sonia Farrakh, and Della Saunders operated under a culture of unchecked production, with no quality control, no accreditation, and no proper protocols. The Inspector General's Office is criticized for failing to retest high-output chemists' samples despite clear red flags, effectively whitewashing the scandal. Key testimony reveals that the lab lacked a quality system, used homemade standards, ignored expiration dates, and relied on a single-chemist model that enabled fraud. Jamie exposes the perjury of key figures like Chuck Salemi and Peter Prio, who claimed to follow standards like SwigDrug while knowingly misrepresenting their scope. The episode underscores how the entire system was designed to produce convictions, not truth, with the drug war’s machinery prioritizing outcomes over science. Jamie calls on listeners to attend trials, engage with the community, and support the podcast to continue investigative work, especially as he prepares to expose further corruption in the Braintree Evidence Office. Key takeaways include: 1) The absence of a formal quality system in the Hinton Lab made scientific integrity impossible; 2) The Inspector General’s failure to retest high-production chemists’ samples enabled a cover-up; 3) Homemade, expired standards were used in testing, undermining reliability; 4) SwigDrug was misrepresented as only for trafficking cases, when it was used across all lab operations; 5) The lab’s culture prioritized conviction rates over accuracy; 6) Multiple chemists and supervisors knowingly falsified records or evaded questions under oath; 7) The state’s refusal to accredit the lab signals institutional complicity; 8) The drug war’s infrastructure profits from selling legal drugs to states for testing, creating a perverse incentive.